Chemical Compound

Lopinavir; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI); 1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-; (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide; A 157378.0; ABT 378; Aluviran;

CAS Registry Number 192725-17-0
返回搜索 申请报价
Lopinavir; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI); 1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-; (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide; A 157378.0; ABT 378; Aluviran; 结构式
Primary record

Lopinavir; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI); 1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-; (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide; A 157378.0; ABT 378; Aluviran;

库存
7,662 克
纯度
99.2 %
CAS
192725-17-0

化合物标识与属性

CAS
192725-17-0
PubChem CID
92727
SMILES
CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O
Canonical SMILES
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O

名称与同义词

  • Lopinavir
  • Aluviran
  • Koletra
  • 192725-17-0
  • ABT-378
  • Kaletra
  • Lopinavirum
  • Aluvia
  • koletr
  • Lopimune
  • Lopinavir-
  • Lopinavir?
  • Mixture Name
  • Lopinavir RS
  • Lopinavir CRS
  • 1mui
  • 2qhc
  • 2rkf
  • 2rkg
  • 3ogq
  • ABT 378
  • Kaletra (TN)
  • Lopinavir & PLGA
  • Aluvia (TN)
  • Component of Kaletra
  • Lopinavir (Standard)
  • Kaletra (LPV+RTV)
  • RefChem:5960
  • 2o4s
  • 2q5k
  • 4l1a
  • LOPINAVIR [INN]
  • LOPINAVIR [JAN]
  • Lopinavir [USAN:INN:BAN]
  • LOPINAVIR [MI]
  • Lopinavir, ABT 378
  • CHEBI:31781
  • AC1L3OPJ
  • LOPINAVIR [USAN]
  • ABT378
  • LOPINAVIR [VANDF]
  • Lopinavir (ABT-378)
  • DTXSID8046456
  • ABT-378, LOPINAVIR
  • CHEMBL729
  • D0U5GB
  • Epitope ID:231715
  • LOPINAVIR [MART.]
  • LPV & AAG
  • LOPINAVIR [USP-RS]
  • LOPINAVIR [WHO-DD]
  • LOPINAVIR [WHO-IP]
  • C37H48N4O5
  • Lopinavir (JAN/USP/INN)
  • Lopinavir, (s-(2s,4s,5s))-
  • RS-346
  • SCHEMBL21775
  • DTXCID6026456
  • LOPINAVIR [EMA EPAR]
  • UNII-2494G1JF75
  • cc-620
  • HSDB 8138
  • Lopinavir (JAN/USAN/INN)
  • MLS003915624
  • MLS004774152
  • MLS006011206
  • ABT-378; LOPINAVIR
  • ABT-378/r
  • Lopinavir - Bio-X trade mark
  • Lopinavir [USAN:USP:INN:BAN]
  • MFCD22373646
  • AIDS032937
  • orb1307985
  • A 157378.0
  • A-157378.0
  • LOPINAVIR [ORANGE BOOK]
  • 2494G1JF75
  • LOPINAVIR [EP MONOGRAPH]
  • CTK8E9936
  • GTPL11504
  • AOB1042
  • J05AE06
  • LOPINAVIR [USP MONOGRAPH]
  • KALETRA COMPONENT LOPINAVIR
  • KJHKTHWMRKYKJE-SUGCFTRWSA-N
  • MFCD22628840
  • BCPP000184
  • GLXC-02734
  • ABT 157378
  • LOPINAVIRUM [WHO-IP LATIN]
  • CID92727
  • EX-A4008
  • KS-000000TF
  • MSK10437
  • ZINC3951740
  • Tox21_112204
  • A-157378-0
  • BDBM50180655
  • CID:92727
  • EBC-06069
  • HB7108
  • HY-14588R
  • Lopinavir & alpha1-acid glycoprotein
  • Lopinavir for system suitability CRS
  • NCGC00164576-02
  • s1380
  • Lopinavir for peak identification CRS
  • AKOS025243115
  • C37-H48-N4-O5
  • Lopinavir & Poly-lactide-co-glycolide
  • Tox21_112204_1
  • AN-6726
  • BCP9000857
  • CCG-270285
  • CS-2077
  • DB01601
  • FL16558
  • KS-1436
  • RTR-008945
  • Lopinavir 100 microg/mL in Acetonitrile
  • NCGC00164576-01
  • NCGC00164576-03
  • NCGC00164576-04
  • BL164636
  • HY-14588
  • SMR002529581
  • SY073885
  • A 157378
  • SID:126522368
  • (S)-N-((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • AB0071033
  • LS-173766
  • TR-008945
  • A2584
  • A8204
  • CAS-192725-17-0
  • FT-0631202
  • L0377
  • NS00008581
  • SW219767-1
  • (2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
  • J1.543.461I
  • LPV
  • A10537
  • C12871
  • D01425
  • SBI-0654097.0001
  • (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
  • 2-CHLORO-6-FLUORO-N-HYDROXY-BENZAMIDINE
  • 24233-EP2298761A1
  • 24233-EP2298783A1
  • 24233-EP2314590A1
  • A157378.0
  • AB01274785-01
  • AB01274785_02
  • EN300-7402887
  • 111995-EP2272516A2
  • 111995-EP2298761A1
  • 111995-EP2298783A1
  • A813594
  • D061466
  • Q422585
  • SR-01000931910
  • SR-01000931910-2
  • A-1573780
  • BRD-K99451608-001-02-4
  • BRD-K99451608-001-07-3
  • Lopinavir, 99%, HIV protease inhibitor - 10mg 10mg
  • (1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
  • (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
  • N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
  • Z2235801862
  • B0084-086623
  • Lopinavir Working Standard (Secondary Reference Standard)
  • (2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanamide
  • 1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahyrdo-alpha-1-methylethyl)-2-oxo-, (alphaS)-
  • AB1
  • (?-S)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-?-(1-methylethyl)-
  • (|_S)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|_-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • (|AS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • (1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2-OXO-1(2H)-PYRIMIDINEACETAMIDE
  • (2S)-N-((1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • (2S)-N-((2S,4S,5S)-5-((2-(2,6-dimethylphenoxy)acetyl)amino)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
  • (2S)-N-[(1S,3S,4S)-1-Benzyl-3-hydroxy-4-(2,6-dimethylphenoxyacetylamino)-5-phenylpentyl]-2-(2-oxohexahydropyrimidine-1-yl)-3-methylbutanamide
  • (2S)-N-[(1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • (2S)-N-[(2R,4S,5S)-5-[[2-(2,6-DIMETHYLPHENOXY)ACETYL]AMINO]-4-HYDROXY-1,6-DIPHENYL-HEXAN-2-YL]-3-METHYL-2-(2-OXO-1,3-DIAZINAN-1-YL)BUTANAMIDE
  • (2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • (2S)-N-{(2S,4S,5S)-5-[2-(2,6-Dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
  • (alphaS)-Tetrahydro-N-[(alphaS)-alpha-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenethyl]-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
  • (S)-N-((2R,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexn-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-.alpha.-(1-methylethyl)-2-oxo-, (aS)-
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-(9CI)
  • 1(2H)-pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-
  • 1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-
  • 1(2H)-pyrimidineacetamide,N-((1S,3S,4S)-4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-1-methylethyl)-2-oxo-,(alphaS)-
  • 1-[(S)-1-[[(S)-alpha-[(2S,3S)-3-(2,6-Dimethylphenoxyacetylamino)-2-hydroxy-4-phenylbutyl]phenethyl]carbamoyl]-2-methylpropyl]-3,4,5,6-tetrahydropyrimidine-2(1H)-one
  • 192725-50-1
  • Lopinavir; (2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-; 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI); 1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-; (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide; A 157378.0; ABT 378; Aluviran;